MHRA Class 2 Medicines Recall: Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)
MHRA Class 2 Medicines Recall: Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)
May 17, 2022
Class 2 Medicines recall: Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)
Drug alert number: EL (22) A/23
Date issued: 17th May 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)
Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the tablet core being partially exposed.
| Batch Number | Company’s Reference | Expiry Date | Pack Size | First Distributed |
| 107082 | 6949U | 04/2023 | 30 | 03/2022 |
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For more information, medical or supply enquiries, please contact joanne.fishwick@maxearn.co.uk or radoslaw.bandomir@maxearn.co.uk
Posted in: Dispensing & Supply
